Home » Topics » Regulatory » Patents

Patents
RSS

MDR-reversing agents reported by Nikken Chemicals

Nov. 12, 1997

New neuroprotectants disclosed by Nippon Shinyaku

Nov. 12, 1997

Azolobenzazepines claimed by Zeneca for use in stroke

Nov. 11, 1997

Fujisawa reports heterocyclic glutamate receptor antagonists

Nov. 11, 1997

PPAR-gamma agonists for endocrine and metabolic disorders

Nov. 11, 1997

Neurogen describes dopamine receptor subtype-specific ligands

Nov. 11, 1997

New oxazolidinone antibiotics described by Zeneca

Nov. 11, 1997

New taxoids from RPR

Nov. 10, 1997

Inhibitors of ECE prepared at Roussel Uclaf/INSERM

Nov. 10, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 11, 2025.
UK launches strategy to replace animals in research as scientists voice concern
BioWorld
The U.K. government has published a road map for phasing out animal testing in life sciences research and announced £75 million (US$98.6 million) for work to...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld Science
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...
Up the bladder ladder, Engene tweak means phase II bell rung
BioWorld
Engene Holdings Inc.’s protocol amendment to its phase II trial with detalimogene voraplasmid in bladder cancer worked out in a big way, and shares of the firm...